Labophar
ActiveSummary
Labophar has been active since 2015 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.5m and a net result of -€375,714. Equity is shrinking by ~9.8% per year across the filed fiscal years. Its solvency ranks better than 41% of 4613 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability53▲+2
Solvency54▼-4
Growth31=
Track record100
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €40,000 at 30 days acceptable
Liquidity short (current ratio 0.76 against 0.61 in 2024; short-term debt: 23% of total assets), and 71.4% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 68
Relative position
BE, all sectors
reference
Real estate activities (NACE 68)
about 43% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
28.6%
Return on assets
-4.3%
Age of the figures
9 mo
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025Net result per financial year
1819202122232425
2018 to 2025 · latest year -€375,714
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-06-2026, 31 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
31 d early
2024
9 d early
2023
23 d early
2022
31 d late
2021
20 d early
2020
12 d early
2019
41 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 3 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 11 July (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
29-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check Which other companies belong to the same group?Ceres Invest · 12 companies How does this company compare with its sector?Sector benchmark
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, full schema
Turnover
€406,703▼ 0.2%
2024 · €407,526
EBIT margin
-28.9%▲ 1.7pp
2024 · -30.6%
Net result
-€375,714▲ 10.1%
2024 · -€417,897
Working capital
-€483,876▲ 19.8%
2024 · -€603,410
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 68, Real estate activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Turnover€4.5m▼ 9.2%€4.4m▼ 2.6%€1.5m▼ 66.5%€407,526▼ 72.4%€406,703▼ 0.2%
Operating result-€53,505-€274,150▼ 412%-€209,611▲ 23.5%-€124,821▲ 40.5%-€117,551▲ 5.8%
Net result-€407,291below the sector's middle half▼ 185%-€511,299below the sector's middle half▼ 25.5%-€463,149below the sector's middle half▲ 9.4%-€417,897below the sector's middle half▲ 9.8%-€375,714below the sector's middle half▲ 10.1%
EBIT margin-1.2%▼ 4.8pp-6.2%▼ 5.0pp-14.2%▼ 8.0pp-30.6%▼ 16.4pp-28.9%▲ 1.7pp
Equity€4.2mabove the sector's middle half▼ 8.8%€3.7mabove the sector's middle half▼ 12.0%€3.3mabove the sector's middle half▼ 12.4%€2.9mabove the sector's middle half▼ 12.8%€2.5mwithin the sector's middle half▼ 13.2%
Total assets€11.5mabove the sector's middle half▼ 6.4%€11.2mabove the sector's middle half▼ 2.6%€8.8mwithin the sector's middle half▼ 21.2%€8.6mwithin the sector's middle half▼ 2.2%€8.6mwithin the sector's middle half▲ 0.4%
Debt€7.0m▼ 3.2%€7.2m▲ 2.6%€5.5m▼ 23.1%€5.8m▲ 4.0%€6.2m▲ 7.1%
Working capital-€60,717within the sector's middle half€235,166within the sector's middle half-€761,108below the sector's middle half-€603,410below the sector's middle half▲ 20.7%-€483,876below the sector's middle half▲ 19.8%
Solvency37.0%within the sector's middle half▼ 1.0pp33.4%within the sector's middle half▼ 3.6pp37.1%within the sector's middle half▲ 3.7pp33.1%within the sector's middle half▼ 4.0pp28.6%within the sector's middle half▼ 4.5pp
Current ratio0.97within the sector's middle half▼ 0.321.11within the sector's middle half▲ 0.140.42below the sector's middle half▼ 0.690.61within the sector's middle half▲ 0.180.76within the sector's middle half▲ 0.15
Return on assets (ROA)-3.6%below the sector's middle half▼ 2.4pp-4.6%below the sector's middle half▼ 1.0pp-5.3%below the sector's middle half▼ 0.7pp-4.9%below the sector's middle half▲ 0.4pp-4.3%below the sector's middle half▲ 0.5pp
Staff (FTE)13.1above the sector's middle half▲ 21.3%11.7above the sector's middle half▼ 10.7%0below the sector's middle half▼ 100%
above
within
below
the middle half (P25 to P75) of NACE 68, Real estate activities, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
The operating result stays negative: a loss of €117,551 in 2025 against €124,821 in 2024; the loss shrinks.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €8.6m
Fixed assets
€7.1m ▼ 7.1%
Current assets
€1.5m ▲ 62.5%
Equity and liabilities €8.6m
Equity
€2.5m ▼ 13.2%
Debt
€6.2m ▲ 7.1%
Debt's share of the balance-sheet total rises from 66.9% to 71.4%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€419,808▼
2024 · €436,175
Cash flow
€161,645▲
2024 · €143,099
Debt to equity
2.49▲
2024 · 2.02
ROE
-15.2%▼
2024 · -14.6%
Interest coverage
1.99▲
2024 · 1.68
Debt ≤ 1 year
€2.0m▲
2024 · €1.5m
Debt > 1 year
€4.0m=
2024 · €4.0m
Income taxes
€45,941▲
2024 · €33,380
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Operating income70/76A | €4.6m | €4.6m | €1.6m | €473,484 | €444,125 | ▼ 6.2% |
| Turnover70 | €4.5m | €4.4m | €1.5m | €407,526 | €406,703 | ▼ 0.2% |
| Other operating income74 | €119,015 | €180,873 | €121,796 | €65,958 | €25,906 | ▼ 60.7% |
| Non-recurring operating income76A | - | - | €50 | €0 | €11,516 | - |
| Operating charges60/66A | €4.7m | €4.9m | €1.8m | €598,305 | €561,676 | ▼ 6.1% |
| Goods for resale, raw materials and consumables60 | €1.6m | €1.5m | €1.0m | €0 | - | - |
| Purchases600/8 | €1.9m | €1.6m | €25,153 | €0 | - | - |
| Change in stocks: decrease (increase)609 | -€299,257 | -€57,536 | €1.0m | €0 | - | - |
| Services and other goods61 | €1.5m | €1.5m | €145,043 | €33,643 | €22,640 | ▼ 32.7% |
| Remuneration, social security and pensions62 | €1.0m | €1.1m | €34,117 | €0 | - | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €585,308 | €608,602 | €577,145 | €560,996 | €537,359 | ▼ 4.2% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4 | €7,561 | -€8,919 | -€9,516 | €912 | €0 | ▼ 100% |
| Provisions for liabilities and charges: additions (uses and reversals)635/8 | -€139,664 | €34,353 | -€242,824 | €0 | - | - |
| Other operating charges640/8 | €17,052 | €38,979 | €5,075 | €1,484 | €1,677 | ▲ 13.0% |
| Non-recurring operating charges66A | €145,530 | €27,636 | €250,594 | €1,271 | €0 | ▼ 100% |
| Operating profit (loss)9901 | -€53,505 | -€274,150 | -€209,611 | -€124,821 | -€117,551 | ▲ 5.8% |
| Financial income75/76B | €19 | €135,189 | €9,455 | €0 | €89 | ▲ 149,000% |
| Recurring financial income75 | €19 | €632 | €9,455 | €0 | €89 | ▲ 149,000% |
| Other financial income752/9 | €19 | €632 | €9,455 | €0 | €89 | ▲ 149,000% |
| Non-recurring financial income76B | - | €134,557 | €0 | - | - | - |
| Financial charges65/66B | €295,116 | €352,656 | €247,092 | €259,696 | €212,312 | ▼ 18.2% |
| Recurring financial charges65 | €295,116 | €269,771 | €247,092 | €259,696 | €212,312 | ▼ 18.2% |
| Debt charges650 | €277,605 | €259,584 | €244,471 | €259,072 | €210,776 | ▼ 18.6% |
| Other financial charges652/9 | €17,511 | €10,187 | €2,621 | €625 | €1,536 | ▲ 146% |
| Non-recurring financial charges66B | - | €82,885 | €0 | - | - | - |
| Profit (loss) for the period before taxes9903 | -€348,602 | -€491,617 | -€447,249 | -€384,517 | -€329,773 | ▲ 14.2% |
| Income taxes67/77 | €58,690 | €19,682 | €15,900 | €33,380 | €45,941 | ▲ 37.6% |
| Taxes670/3 | €58,811 | €20,033 | €15,900 | €33,380 | €45,941 | ▲ 37.6% |
| Tax adjustments and reversals of tax provisions77 | €121 | €351 | €0 | - | - | - |
| Profit (loss) for the period9904 | -€407,291 | -€511,299 | -€463,149 | -€417,897 | -€375,714 | ▲ 10.1% |
| Profit (loss) for the period to be appropriated9905 | -€407,291 | -€511,299 | -€463,149 | -€417,897 | -€375,714 | ▲ 10.1% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €11.5m | €11.2m | €8.8m | €8.6m | €8.6m | ▲ 0.4% |
| Fixed assets21/28 | €9.4m | €8.9m | €8.3m | €7.7m | €7.1m | ▼ 7.1% |
| Intangible fixed assets21 | €4.5m | €3.9m | €3.3m | €2.8m | €2.3m | ▼ 18.6% |
| Tangible fixed assets22/27 | €80,332 | €95,130 | €57,361 | €26,031 | €7,174 | ▼ 72.4% |
| Plant, machinery and equipment23 | €27,028 | €16,875 | €6,725 | €3,016 | €2,257 | ▼ 25.2% |
| Furniture and vehicles24 | €53,304 | €78,256 | €50,636 | €23,015 | €4,918 | ▼ 78.6% |
| Financial fixed assets28 | €4.8m | €4.8m | €4.8m | €4.8m | €4.8m | = |
| Affiliated companies280/1 | €4.8m | €4.8m | €4.8m | €4.8m | €4.8m | = |
| Participating interests280 | €4.8m | €4.8m | €4.8m | €4.8m | €4.8m | = |
| Current assets29/58 | €2.1m | €2.3m | €559,469 | €924,847 | €1.5m | ▲ 62.5% |
| Stocks and contracts in progress3 | €950,794 | €1.0m | €0 | €0 | €0 | - |
| Stocks30/36 | €950,794 | €1.0m | €0 | - | - | - |
| Goods purchased for resale34 | €950,794 | €1.0m | €0 | - | - | - |
| Amounts receivable within one year40/41 | €744,019 | €966,017 | €557,054 | €922,752 | €1.5m | ▲ 62.7% |
| Trade receivables40 | €739,033 | €926,688 | €556,701 | €922,227 | €1.5m | ▲ 62.8% |
| Other amounts receivable41 | €4,985 | €39,329 | €353 | €526 | €0 | ▼ 100% |
| Cash at bank and in hand54/58 | €361,249 | €313,006 | €0 | - | - | - |
| Deferred charges and accrued income490/1 | €32,644 | €21,882 | €2,415 | €2,094 | €1,269 | ▼ 39.4% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €11.5m | €11.2m | €8.8m | €8.6m | €8.6m | ▲ 0.4% |
| Equity10/15 | €4.2m | €3.7m | €3.3m | €2.9m | €2.5m | ▼ 13.2% |
| Contributions10/11 | €4.6m | €4.6m | €4.6m | €4.6m | €4.6m | = |
| Capital10 | €4.6m | €4.6m | €4.6m | €4.6m | €4.6m | = |
| Issued capital100 | €4.6m | €4.6m | €4.6m | €4.6m | €4.6m | = |
| Reserves13 | €208,203 | €208,203 | €208,203 | €208,203 | €208,203 | = |
| Non-distributable reserves130/1 | €208,203 | €208,203 | €208,203 | €208,203 | €208,203 | = |
| Legal reserve130 | €208,203 | €208,203 | €208,203 | €208,203 | €208,203 | = |
| Profit (loss) carried forward14 | -€572,936 | -€1.1m | -€1.5m | -€2.0m | -€2.3m | ▼ 19.1% |
| Provisions and deferred taxes16 | €208,471 | €242,824 | €0 | - | - | - |
| Provisions for liabilities and charges160/5 | €208,471 | €242,824 | €0 | - | - | - |
| Other liabilities and charges164/5 | €208,471 | €242,824 | €0 | - | - | - |
| Amounts payable17/49 | €7.0m | €7.2m | €5.5m | €5.8m | €6.2m | ▲ 7.1% |
| Amounts payable after more than one year17 | €4.8m | €5.1m | €4.0m | €4.0m | €4.0m | = |
| Financial debts170/4 | €4.8m | €0 | - | - | €4.0m | - |
| Subordinated loans170 | €1.2m | €0 | - | - | - | - |
| Credit institutions173 | €3.7m | €0 | - | - | - | - |
| Other loans174 | - | - | - | - | €4.0m | - |
| Other amounts payable178/9 | - | €5.1m | €4.0m | €4.0m | €0 | ▼ 100% |
| Amounts payable within one year42/48 | €2.1m | €2.1m | €1.3m | €1.5m | €2.0m | ▲ 30.0% |
| Current portion of amounts payable after more than one year42 | €635,096 | €0 | - | - | - | - |
| Trade debts44 | €604,273 | €751,756 | €101,405 | €71,289 | €40,311 | ▼ 43.5% |
| Suppliers440/4 | €604,273 | €751,756 | €101,405 | €71,289 | €40,311 | ▼ 43.5% |
| Advances received on contracts in progress46 | €4,541 | €0 | - | - | - | - |
| Taxes, remuneration and social security45 | €210,513 | €289,796 | €106,695 | €49,172 | €165,126 | ▲ 236% |
| Taxes450/3 | €17,372 | €55,292 | €106,695 | €49,172 | €165,126 | ▲ 236% |
| Remuneration and social security454/9 | €193,141 | €234,505 | €0 | - | - | - |
| Other amounts payable47/48 | €695,000 | €1.0m | €1.1m | €1.4m | €1.8m | ▲ 26.5% |
| Accrued charges and deferred income492/3 | €36,436 | €57,852 | €244,471 | €259,072 | €210,776 | ▼ 18.6% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | -€407,291 | -€511,299 | -€463,149 | -€417,897 | -€375,714 | ▲ 10.1% |
| + Depreciation and write-downs630 | €585,308 | €608,602 | €577,145 | €560,996 | €537,359 | ▼ 4.2% |
| Operating cash flow (approximation) | €178,017 | €97,303 | €113,996 | €143,099 | €161,645 | ▲ 13.0% |
| Investment in fixed assets (approximation) | - | -€84,532 | €30,960 | €0 | €6,184 | - |
| Change in cash | - | -€48,243 | -€313,006 | - | - | - |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
30-06
NBB filing
Annual accounts filed
fiscal year 2025 · full schema
2025
22-07
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
08-07
NBB filing
Annual accounts filed
fiscal year 2023 · full schema
2023
31-08
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 31 days late
2022
31-12
Financial
Weakest financial yearnet -€511,299
Net result drops to -€511,299, the lowest in the series; recovery starts the following year.
11-07
NBB filing
Annual accounts filed
fiscal year 2021 · full schema
2021
19-07
NBB filing
Annual accounts filed
fiscal year 2020 · full schema
2020
31-12
Financial
Liquidity triplescurrent ratio 1.29
Current ratio from 0.48 to 1.29; short-term debt falls from €1.9m to €1.9m.
10-09
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 41 days late
2019
27-09
NBB filing
Annual accounts filed
fiscal year 2018 · full schema · 58 days late
2018
28-02
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
14-07
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 14 acts read
About the unread acts
We know of 14 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
14 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Gent · 1 establishment unit since 2015
Ground area
1.1 ha
Building footprint
3,960 m²
Parcel 44062B0301/00D003, Flanders. Linked by address, not a title deed.
23
companies at this address
See who is registered here
1 establishment unit
Labophar
since 20152.249.721.394
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 44062B0301/00D003 | Flanders | 1.1 ha | 1 · 3,960 m² | - |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Structure & network
Part of the group
Ceres Invest
12 companies
Group, risk and exposure
Owners and holdings
1 owner · 2 holdingsChain of control
- Ceres Invest
- Ceres Pharma
- CREDOPHAR
- Labophar
Highest known parent: Ceres Invest. The sources do not say who stands above it.
Owners 1
- CREDOPHARparent100%
Holdings 2
-
100%
-
100%
According to the 2025 annual accounts of Labophar and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
No current directors or connected companies found in the register.
Recognitions · licences · registrations
Legal Entity Identifier
8755001A7X3ALHWDR235
Similar companies · same sector, comparable size
BELVIEW OFFICE
BE 0842.214.574
Londerzeel · Eq €2,476,229
MY BREEX
BE 0897.269.992
Gent · Eq €2,474,775
GROWNERS
BE 0860.002.790
Lasne · Eq €2,474,661
ARCADE
BE 0444.013.243
Liège · Eq €2,481,084
KORTRIJK BUILDING PROJECTS
BE 0455.372.438
Kortrijk · Eq €2,482,489
Of 7,326 companies in sector 68110 we hold annual accounts for 5,390. 2,465 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPublic limited company
Founded30-11-2015
Fiscal year end31-12
Activities, NACEBEL 2025
68110Buying and selling of own real estate
46460Wholesale of pharmaceutical and medical goods
47730Retail sale of pharmaceutical products
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
71209Other technical testing and analysis
72109Other research and development on natural sciences
E-invoicing
Reachable via Peppol
Peppol ID
0208:0643723177
Registered
01-08-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 28 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.